Thalys Medical Technology Group

Thalys Medical Technology Group EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Thalys Medical Technology Group (603716.SS) as of Nov 5, 2026 is -103.63. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 67.98 — a change of -252.44% (lower).

EV/FCF

-103.63

YoY

-252.44%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Thalys Medical Technology Group is 2025 -103.63 . EV/FCF (Enterprise Value to Free Cash Flow) of Thalys Medical Technology Group was 2024 67.98 . It decreases by -252.44% lower compared to the previous year.

The Thalys Medical Technology Group EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-24.62 CNY
Jan 1, 2019
-1,898.12 CNY
Jan 1, 2020
-44.49 CNY
Jan 1, 2021
-29.11 CNY
Jan 1, 2022
-209.00 CNY
Jan 1, 2023
61.88 CNY
Jan 1, 2024
67.98 CNY
Jan 1, 2025
-103.63 CNY
The Thalys Medical Technology Group EV/FCF history
YEAREV/FCFYoY
-103.63-252.44%
67.98+9.86%
61.88-129.61%
-209.00+618.07%
-29.11-34.58%
-44.49-97.66%
-1,898.12+7,610.79%
-24.62-4.98%
-25.91-48.35%
-50.15-106.24%
803.30-129.64%
-2,709.84—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Thalys Medical Technology Group Stock analysis

What does Thalys Medical Technology Group do? Thalys Medical Technology Group Corp, based in Wuhan, China, operates in the Health Care sector with a focus on Biotechnology. The company develops, produces, and sells in vitro diagnostic products, including reagents, consumables, and equipment. It serves major domestic markets such as Hubei, Hunan, Jiangsu, Henan, and Shanghai, employing 1,474 full-time staff. Listed on October 31, 2016, Thalys specializes in diagnostic solutions for the Chinese healthcare market. Thalys Medical Technology Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Thalys Medical Technology Group stock

EV/FCF (Enterprise Value to Free Cash Flow) of Thalys Medical Technology Group is -103.63 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Thalys Medical Technology Group changed from 67.98 to -103.63, representing a -252.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Thalys Medical Technology Group since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Thalys Medical Technology Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Thalys Medical Technology Group

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Thalys Medical Technology Group